Literature DB >> 22926930

CCN5 Expression in mammals. III. Early embryonic mouse development.

Ronald B Myers1, Kibibi Rwayitare, Lauren Richey, Janis Lem, John J Castellot.   

Abstract

CCN proteins play crucial roles in development, angiogenesis, cell motility, matrix turnover, proliferation, and other fundamental cell processes. Early embryonic lethality in CCN5 knockout and over-expressing mice led us to characterize CCN5 distribution in early development. Previous papers in this series showed that CCN5 is expressed widely in mice from E9.5 to adult; however, its distribution before E9.5 has not been studied. To fill this gap in our knowledge of CCN5 expression in mammals, RT-PCR was performed on preimplantation murine embryos: 1 cell, 2 cell, 4 cell, early morula, late morula, and blastocyst. CCN5 mRNA was not detected in 1, 2, or 4 cell embryos. It was first detected at the early morula stage and persisted to the preimplantation blastocyst stage. Immunohistochemical staining showed widespread CCN5 expression in post-implantation blastocysts (E4.5), E5.5, E6.5, and E7.5 stage embryos. Consistent with our previous study on E9.5 embryos, this expression was not limited to a particular germ layer or cell type. The widespread distribution of CCN5 in early embryos suggests a crucial role in development.

Entities:  

Year:  2012        PMID: 22926930      PMCID: PMC3497895          DOI: 10.1007/s12079-012-0176-0

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  32 in total

1.  Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells.

Authors:  Melchiorre Cervello; Lydia Giannitrapani; Manuela Labbozzetta; Monica Notarbartolo; Natale D'Alessandro; Nadia Lampiasi; Antonina Azzolina; Giuseppe Montalto
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

2.  CCN5 Expression in mammals. II. Adult rodent tissues.

Authors:  Mark R Gray; Jennifer A Malmquist; Matthew Sullivan; Michael Blea; John J Castellot
Journal:  J Cell Commun Signal       Date:  2007-11-13       Impact factor: 5.782

3.  Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation.

Authors:  R Zhang; L Averboukh; W Zhu; H Zhang; H Jo; P J Dempsey; R J Coffey; A B Pardee; P Liang
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

4.  Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro.

Authors:  W H Fan; M Pech; M J Karnovsky
Journal:  Eur J Cell Biol       Date:  2000-12       Impact factor: 4.492

5.  Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions.

Authors:  S Kumar; A T Hand; J R Connor; R A Dodds; P J Ryan; J J Trill; S M Fisher; M E Nuttall; D B Lipshutz; C Zou; S M Hwang; B J Votta; I E James; D J Rieman; M Gowen; J C Lee
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

6.  Expression and regulation of WISP2 in rheumatoid arthritic synovium.

Authors:  Ichiro Tanaka; Masako Morikawa; Toshiyuki Okuse; Masayori Shirakawa; Kazushi Imai
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

Review 7.  CCN proteins: multifunctional signalling regulators.

Authors:  Bernard Perbal
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

8.  CCN5 expression in mammals : I. Embryonic and fetal tissues of mouse and human.

Authors:  Jennifer A Jones; Mark R Gray; Beatriz Enes Oliveira; Manuel Koch; John J Castellot
Journal:  J Cell Commun Signal       Date:  2007-11-20       Impact factor: 5.782

9.  Estrogen induces CCN5 expression in the rat uterus in vivo.

Authors:  Holly R Mason; Danielle Grove-Strawser; Beverly S Rubin; Romana A Nowak; John J Castellot
Journal:  Endocrinology       Date:  2003-11-06       Impact factor: 4.736

10.  Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene.

Authors:  Emma Heath; Dalal Tahri; Elisabetta Andermarcher; Paul Schofield; Stewart Fleming; Catherine A Boulter
Journal:  BMC Dev Biol       Date:  2008-02-20       Impact factor: 1.978

View more
  6 in total

1.  Emerging roles of CCN proteins in vascular development and pathology.

Authors:  Philip A Klenotic; Chao Zhang; Zhiyong Lin
Journal:  J Cell Commun Signal       Date:  2016-05-30       Impact factor: 5.782

Review 2.  Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities.

Authors:  Izabela Krupska; Elspeth A Bruford; Brahim Chaqour
Journal:  Hum Genomics       Date:  2015-09-23       Impact factor: 4.639

Review 3.  Extracellular Matrix, a Hard Player in Angiogenesis.

Authors:  Maurizio Mongiat; Eva Andreuzzi; Giulia Tarticchio; Alice Paulitti
Journal:  Int J Mol Sci       Date:  2016-11-01       Impact factor: 5.923

4.  Tissue distribution and transcriptional regulation of CCN5 in the heart after myocardial infarction.

Authors:  Sima Zolfaghari; Ole Jørgen Kaasbøll; M Shakil Ahmed; Fabian A Line; Else Marie V Hagelin; Vivi T Monsen; Håvard Attramadal
Journal:  J Cell Commun Signal       Date:  2021-12-01       Impact factor: 5.908

5.  Characterization of bone morphology in CCN5/WISP5 knockout mice.

Authors:  Jie Jiang; Gexin Zhao; Karen M Lyons
Journal:  J Cell Commun Signal       Date:  2018-02-02       Impact factor: 5.908

Review 6.  CCN5/WISP2 and metabolic diseases.

Authors:  John R Grünberg; Johannes Elvin; Alexandra Paul; Shahram Hedjazifar; Ann Hammarstedt; Ulf Smith
Journal:  J Cell Commun Signal       Date:  2017-12-15       Impact factor: 5.782

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.